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The endoplasmic reticulum (ER) is a critical site of protein, lipid, and glucose metabolism, lipoprotein secre-
tion, and calcium homeostasis. Many of the sensing, metabolizing, and signaling mechanisms for these
pathways exist within or on the ER membrane domain. Here, we review the cellular functions of ER, how
perturbation of ER homeostasis contributes to metabolic dysregulation and potential causative mechanisms
of ER stress in obesity, with a particular focus on lipids, metabolic adaptations of ER, and themaintenance of
its membrane homeostasis. We also suggest a conceptual framework of metabolic roundabout to integrate
key mechanisms of insulin resistance and metabolic diseases.Meeting Metabolic Challenges: The Function of the
Endoplasmic Reticulum
Nutrient overload and chronic metabolic diseases are the hall-
marks of the 21st century’s public health challenges. Intake of
calories of all forms (lipids, proteins, and carbohydrates)
demands an adaptive response from the metabolic networks.
Chronic exposure to excessive or inappropriate nutrients places
a heavy burden on adaptive responses that ultimately fail and
cause a pattern of continuous, low-level inflammatory and stress
responses, which we refer to as metaflammation, leading ulti-
mately to the chronic metabolic diseases of modern life: obesity,
diabetes, cardiovascular disease, and other associatedmetabol-
ically driven pathologies (Gregor andHotamisligil, 2011). Interest-
ingly, thedetrimental effectsof acuteovernutritionare rarely toxic,
but instead present a transient challenge that is often adequately
met by the adaptive systems. Long-term exposure, however,
leads to a gradual loss of metabolic homeostasis, and diseases
emerge as consequences of chronic and incremental dysregula-
tion of metabolism. Chronic disease systems then are defined by
changes in both the quality and quantity of substrates utilized for
metabolism and by the inability of the metabolic control mecha-
nisms themselves to manage long-term exposures to nutrients.
Under both normal physiological fluctuations of nutrients and
conditions of excess, the endoplasmic reticulum (ER) has a vital
role in maintaining cellular and organismic metabolic homeo-
stasis. As we will discuss in this article, the ER provides signifi-
cant adaptive capacity to metabolism in managing the periodic
cycles associated with feeding, fasting and other metabolic
demands of limited duration. This organelle however, appears
to be less capable of providing the necessarymetabolic flexibility
to manage chronic and escalating metabolic challenges,
possibly due to a lack of selective pressures to develop such
counter measures during much of its evolution. Thus, the ER
represents both an evolutionary bottleneck leading to common
chronic diseases and a valuable target area for their prevention
and treatment. Several key biological functions of the ER with
relevance to metabolic aspects of ER stress and the unfolded
protein response pathways and their regulation upon exposure
to acute, cyclic, and chronic metabolic stresses will be dis-
cussed in the following sections with a heavier focus on liver.Protein Synthesis and Secretion
Protein biosynthesis is themost enriched and best characterized
function of the rough ER (Song et al., 2010). It is estimated that up
to 75% proteins are synthesized on the ER and all membrane
or secreted proteins that enter the secretary pathway undergo
quality control for proper folding in the ER lumen (Andrews and
Tata, 1971). This is an extraordinary task, as millions of mole-
cules are processed through the ER in seconds, especially in
a highly synthetic organ like the liver, and close to 50% of newly
synthesized proteins fail to assume their properly folded forms.
This aspect of ER function has been extensively reviewed
recently and will not be covered in detail (Braakman and Bulleid,
2011; Hebert and Molinari, 2007). When ER is stressed with the
presence of misfolded proteins, the unfolded protein response
(UPR) is activated (Mori, 2000). The canonical UPR response
(discussed further below) aims to reduce protein synthesis, facil-
itate protein disposal, and enhance protein folding to mitigate
stress. If these efforts fail, UPR can also trigger death responses.
It is curious that despite having a rather robust and elegant
adaptive system, ER still fails to establish a healthy equilibrium
against chronic metabolic challenges. It is therefore possible
that metabolic stress introduces unusual constraints for the
adaptive capacity of the ER. For example, a proper ER response
is dependent on efficient nutrient management and accurate
metabolic control, and a dysfunctional ER, along with other
signals, intersects with a variety of inflammatory and stress
signaling networks that in the long run can also add insult to
the ER injury. Here, we will discuss how ER responses intersect
with metabolism with an emphasis on lipids, not to suggest
a superiority for this aspect of ER biology but since this aspect
of metabolism is often overlooked in the consideration of ER
adaptive biology and constitute the main focus of this article.
Intermediary Lipid Metabolism
The overabundance of nutrients such as lipids in obesity and
caloric surplus leads to aberrant lipid management and ectopic
fat accumulation. This lipotoxicity is a fundamental component
of metabolic disease and insulin resistance (Unger and Scherer,
2010; McGarry and Dobbins, 1999). Lipid metabolism occurs
primarily at the ER, where many of the enzymes involved in inter-
mediary and complex lipid metabolism reside, giving the ER aCell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 623
Figure 1. Lipid Metabolism at the Endoplasmic Reticulum
The depiction of lipid metabolism at the ER is not intended to be compre-
hensive, but to provide a representation of the key functionalities of the ER in
synthesizing, modifying, and exporting lipids.
(A) Key metabolic processes in cholesterol metabolism occurring at the ER
include control of cholesterol synthesis via SREBP release and upregulation of
cholesterol synthesis enzymes including HMG-CoA reductase (HMGR),
oxidation of excess membrane cholesterol by Cyp7a, a key step in liberating
cholesterol for bile acid production and secretion, and the acylation of
cholesterol into cholesterol esters by acyl-CoA:acyltransferase (ACAT), which,
like DGAT, creates a highly hydrophobic entity that seeds the formation of lipid
droplets within the membrane phase.
(B) Key activities in fatty acid metabolism include synthesis of saturated fatty
acids (SFA) via fatty acid synthase (FAS) and their elongation and desaturation
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primary mechanisms for managing lipid substrates at the ER
are presented in Figure 1A. Among lipids, careful control of
cholesterol levels is particularly important as cholesterol exerts
a strong ordering effect on membranes through its hydrophobic
interactions with the fatty acids present in phospholipids.
Control of cellular cholesterol levels occurs at the ER through
pathways that sense the level of cholesterol or cholesterol
derivatives within the ER membrane itself and relay signals
controlling cholesterol synthesis and clearance. The primary
modes of cholesterol regulation at the ER include initiation of
cholesterol synthesis via the SCAP/SREBP2 pathway under
conditions of low ER cholesterol (Brown and Goldstein, 2009),
conversion of cholesterol to oxysterols and eventually bile acids
(Russell, 2003) for excretion in bile, and the production of choles-
terol esters, which can migrate out of the membrane into lipid
droplets by virtue of their hydrophobic properties (Martin and
Parton, 2006). Given that cholesterol is an evolutionarily
conserved building block and that it is critical to cell function, it
is likely that other pathways exist for sensing cholesterol and
triggering regulation of metabolism, but it is not yet clear how
quantitatively important those pathways are for ER cholesterol
homeostasis.
The composition of the intracellular fatty acid pool is also regu-
lated by the ER in order to meet the basic cellular demands for
synthesizing complex lipids with a broad variety of structures
(Figure 1B). Like cholesterol, the fatty acid composition of aggre-
gate lipid structures has a profound impact on the physical
properties of cellular membranes. The tools for modifying the
structure of fatty acids include desaturases, elongases, and
b oxidation cycles. The desaturases and elongases occur mainly
in the ER (Miyazaki and Ntambi, 2008); thus, the ER is a crucial
site for maintaining all aspects of fatty acid and lipid homeostasis
in cells. Additionally, the process of synthesizing fatty acids de
novo is controlled at least in part by fatty acid sensing mecha-
nisms within the ER via the feedback inhibition of the release of
the transcription factor SREBP-1 (Horton, 2002). In humans the
majority of de novo lipogenesis takes place in the liver while
adipose tissue de novo lipogenesis is suppressed (Shrago
et al., 1971). Consequently, human adipose tissue lipids are
mainly derived from the accumulation and modification of diet
and liver-produced fatty acids. This is a critical consideration in
making correlative evaluations related to the total amount of deto longer-chainSFAandmonounsaturated fatty acids (MUFA)by the long-chain
elongase (LCE) and stearoyl-CoA desaturase (SCD), respectively. Synthesis of
fatty acids is controlled by SREBP-1. Essential (polyunsaturated, PUFA) fatty
acids are metabolized by desaturation and elongation of highly unsaturated
fatty acids (HUFA)bydesaturases (FADS) andelongases (ELOVL), respectively.
(C) Key activities in the synthesis of glycerolipids including phospholipids (PL)
and triglycerides (TG) include glycerol-3-phosphate acyltransferase (GPAT),
which acylates the sn-1 position of glycerol-3-phosphate, acylglycer-
olphosphate acyltransferase (AGPAT), which acylates the sn-2 position,
phosphatidic acid phosphohydrolase (PAPH), which forms diacylglycerol, the
diacylglycerol choline/ethanolaminephosphotransferases (CEPT) which form
either phosphatidylcholine or phosphatidylethanolamine from diacylglycerol,
and monoacylglycerol acyltransferase (MGAT) or diacylcglycerol acyl-
transferase (DGAT) which can acylate diacylglycerol to form triacylglycerol.
The formation of triacylated TG seed the formation of a nonpolar phase within
the membrane domain, and this can grow and mature into either a lipid droplet
or a VLDL particle. Other important phospholipid synthesis pathways exist at
the ER but are not shown.
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are strong indicators of hepatic lipogenesis.
Glycerolipid Synthesis, Lipid Droplet Formation,
and VLDL Assembly
There are two primary forms of complex lipids in the endo-
plasmic reticulum: amphiphilic phospholipids and neutral lipids
such as triglycerides and cholesterol esters (Figure 1C). Phos-
pholipids are essential for the assembly of membranes and the
vesicles that traffic proteins and other entities to the rest of the
cell. Triglycerides and cholesterol esters are sinks for excess
fatty acid and cholesterol, and by virtue of their hydrophobic
nature, seed the formation of lipid droplets within the ER
membrane (Martin and Parton, 2006; Farese and Walther,
2009). The formation of lipid droplets protects the cell from accu-
mulation of excess fatty acids and maintains the integrity of the
ER membrane. However, it may also consume ER membranes
during this process, although the significance of this biology to
ER function is not known. The primary pathway for the syntheses
of both phospholipids and triglycerides is the Kennedy pathway,
which sequentially acylates glycerol phosphate to phospholipids
or triglycerides and is largely present at the ER (Fagone and
Jackowski, 2009). Control of both the fatty acid composition
and the phospholipid type distribution has important effects on
membrane function (Sprong et al., 2001). Notably, the assembly
of lipid droplets for intracellular lipid storage requires a specific
increase in the synthesis of phosphatidylcholine at the ER,
potentially putting the balance of the ERmembrane composition
at risk (Krahmer et al., 2011). Thus, lipid metabolism plays an
important role in maintaining ER membrane function and its
disturbance, even in small ways, can pose major challenges
that lead to ER stress andmetabolic dysfunction (Fu et al., 2011).
The synthesis and compositional control of lipids in the ER also
needs to be tightly coordinated with lipid trafficking and secre-
tion. Hepatocytes and other cell types have the capacity to
assemble and secrete ApoB-containing lipoproteins comprising
ApoB, triglycerides, cholesterol esters, and phospholipids. In
hepatocytes, lipoprotein secretion serves not only to deliver lipid
to peripheral tissues but also to clear the hepatocyte of excess
cholesterol and fatty acid. Interestingly, the use of the VLDL
assembly mechanism to clear lipid comes at the cost of
increasing protein synthesis and lipid metabolism demands on
the ER, and the regulation of this process appears tightly linked
to fatty acid metabolism (Caviglia et al., 2011; Ota et al., 2008).
Consequently, signaling networks integral to the UPR program
are directly linked to lipogenic pathways and lipid secretion, to
coordinate the metabolic needs of a recovering or adapting
ER. It is also critical to mention that the biology of lipids is not
limited to their properties as building blocks and substrates but
also includes specific signaling molecules and hormones that
control local and systemic metabolic responses, which will be
discussed further in the following sections.
Calcium Homeostasis
Calcium and phosphate are two vital cellular signaling mole-
cules. However, to prevent the formation of calcium phosphate
precipitates, mechanisms have evolved to extrude the vast
majority of calcium out of the cell. As a result, the ratio of intracel-
lular calcium concentration to extracellular calcium concentra-
tion is maintained around 1:100,000 (10 nM versus 1 mM)
(Clapham, 2007). Cellular processes that constantly requirehigh levels of calcium are compartmentalized into membrane-
enveloped organelles that include ER, mitochondria, Golgi
body, and others, and they require dedicated pumps to maintain
proper calcium concentrations. The calcium concentration in the
ER is roughly 10,000 times higher than that in the cytosol
(0.1 mM versus 10 nM), and this gradient is maintained by
the active transport function of Sarco-/endoplasmic reticulum
calcium ATPase (SERCA) (Moore et al., 1975). Many ER chaper-
ones and post-translational modification enzymes depend on
calcium for proper function, and maintaining ER calcium stores
is critical for proper protein production (Michalak et al., 2002).
Additionally, the maintenance of extremely low cytosolic calcium
concentrations allows for a broad range of calcium-mediated
signaling events, most of which involve the controlled and tran-
sient release of calcium from the ER (Berridge et al., 2003). The
function of calcium transporters and channels is also modulated
by membrane lipid composition, protein-protein interaction, and
a range of post-translational modifications (Traaseth et al., 2008;
Li et al., 2009; Fu et al., 2011). Therefore, ER provides a platform
for the crosstalk of many cellular signaling pathways and meta-
bolic regulatory events through calcium fluxes and metabolism
(Verkhratsky, 2005).
ER Stress and Its Contribution to Insulin Resistance
and Diabetes
In the presence of misfolded proteins, ER initiates the unfolded
protein response through the actions of cannonical sensors
PERK, IRE1, and ATF6 in an attempt to restore ER homeostasis
(Walter and Ron, 2011; Malhotra and Kaufman, 2007; Mori,
2000). Collectively, these branches operate through suppression
of protein synthesis, facilitation of protein degradation, and
increase the availability of chaperones and, if all fails, can drive
cells to apoptosis (Figure 2A). An important link that led to the
concept of metabolic regulation by ER emerged from the recog-
nition of its ability to regulate insulin action and glucose metab-
olism (Ozcan et al., 2004; Hotamisligil, 2010b). Insulin is one of
the primary anabolic hormones in the body, stimulating glucose
and lipid uptake into the peripheral tissues and the synthesis of
proteins, glycogen, and lipids therein. As the major cellular
anabolic organelle, ER plays a critical role in insulin-induced
synthetic and growth pathways and the eventual development
of obesity under permissive environmental exposures as well
as the emergence of metabolic disorders during the course of
chronic over-nutrition and obesity (Hotamisligil, 2010b). There
are at least two mechanisms by which ER stress counters whole
body insulin-dependent biological processes: tissue insulin
resistance and b cell failure resulting in impaired insulin produc-
tion. While, these are the main aspects discussed here, it is
critical to recognize, however, that the ER’s impact on metabo-
lism goes beyond the boundaries of insulin to include direct
actions on many metabolic pathways independent of this
hormone, and beyond diabetes as metabolic disease.
ER Stress and Insulin Production
A robust ER function is paramount to b cell function and survival
with or without insulin resistance. This is evident in bothmice and
man, where mutations in PERK result in permanent neonatal
diabetes, such as the case in Wolcott-Rallison syndrome (Dele´-
pine et al., 2000). Similar observations have also supported the
role of this branch of the UPR in b cell function in models whereCell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 625
Figure 2. Cannonical Unfolded Protein Response
(A) Canonical UPR. Unfolded or misfolded proteins activate the three ER stress sensors (IRE1, PERK, and ATF6) by releasing them from BiP binding. IRE1 is
a ribonuclease that splices and religatesHAC1/Xbp1 transcripts for the synthesis of an active transcription factor to induce the expression of chaperones and lipid
synthesis enzymes. PERK is a kinase that phosphorylates eIF2a and suppresses protein synthesis. ATF6 is a transcription factor that once released from ER will
travel to the Golgi body, cleaved and translocated to the nucleus to activate the transcription of chaperone genes. Upon severe stress conditions, the synthesis
of ATF4 is enhanced in an eIF2a phosphorylation independent manner that promotes apoptosis.
(B) Contribution of UPR to both inflammatory and metabolic abnormalities in obesity. UPR activates JNK at least through three different mechanisms: PKR,
IRE1/TRAF/ASK1, and PERK/CHOP/ERO1L/IP3R/CaMK. JNK promotes inflammation and apoptosis by phosphorylating and activating AP1 family of tran-
scription factors. JNK also phosphorylates IRS molecules on serine residues and act as an important mediator of insulin resistance. UPR can also modulate
gluconeogenesis and lipogenesis in multiple ways. First, the insulin resistance resulting from UPR prevents the inactivation of Foxo1 and its gluconeogenic
program by insulin. Second, the nuclear form of ATF6 inhibits gluconeogenesis and lipogenesis, respectively, by binding to TORC2 and SREBP2. Third, the
spliced form of Xbp1 can directly or indirectly (through SREBP1) activate lipogenesis program while inhibiting gluconeogenesis. Lastly, eIF2a phosphorylation
leads to the synthesis of CHOP and the activation of lipogenesis programs through CEBPa/b. The sometimes opposing effects of UPR in regulating gluco-
neogenesis and lipogenesis are context dependent. The lipogenesis program in the obese liver also alters the membrane lipid composition of ER, inhibition
of SERCA and propagation of ER stress. Abbreviations: IRE1, inositol required 1; PERK, PKR-like endoplasmic reticulum localized kinase; ATF6, activating
transcription factor 6.
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et al., 2002). In the presence of insulin resistance, b cells prolif-
erate and secrete more insulin, which can account for up to
50% of total protein synthesis. When facing a constant demand
of insulin in the context of obesity and insulin resistance, transla-
tional suppression by eIF2a, while compromising the synthetic
capacity, may not be sufficient to alleviate ER stress if it is not
accompanied by proper coordination of the other mitigating
events, chief among them being the ER folding capacity. This
state creates yet another challenge since constitutively acti-
vated chaperoning programs may also not be compatible with
long-term cellular homeostasis (Trusina et al., 2008), In fact,
this is likely the case for most, if not all, chronic ER stress condi-
tions. For example, while critical for the UPR, when chronically626 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.produced ATF6 can also negatively regulate insulin production
by suppressing the transcription of the proinsulin gene (Seo
et al., 2008), and abnormal constitutive activation of ATF6 and
XBP1 contributes to b cell dysfunction and death in Ins2+/Akita
pancreatic b cells (Nozaki et al., 2004). Curiously, deletion of
Xbp1 also diminishes islet function and survival (Lee et al.,
2011). In other words, the chaperoning aspect of ER homeo-
stasis is a double-edged knife and needs to be precisely regu-
lated; too little or too much can both be dangerous. In addition
to the molecules in canonical UPR responses, there are other
mutations implicated in pancreatic dysfunction and diabetes in
humans, such as the Wolfram Syndrome 1 (Wfs1) gene, which
is induced by ER stress and regulates ER calcium homeostasis
and survival pathways (Ueda et al., 2005; Takei et al., 2006).
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Chronic ER stress is present in liver, b cells, brain, and adipose
tissue in animal models of obesity (Ozcan et al., 2004; Nakatani
et al., 2005), as well as obese humans (Boden et al., 2008;
Sharma et al., 2008; Gregor et al., 2009), but not uniformly in
skeletal muscle (Deldicque et al., 2011). In humans, weight loss
results in reversal of these stress indicators in adipose and liver
tissues (Gregor et al., 2009). Importantly, alleviation of ER stress
by chemical or molecular chaperones improves metabolic
control and insulin sensitivity in animal models (Ozcan et al.,
2006; Kammoun et al., 2009; Ozawa et al., 2005) and, most
importantly, in obese humans (Kars et al., 2010; Xiao et al.,
2011), indicating that ER dysfunction is a critical contributor to
chronic metabolic deterioration. The mechanism by which ER
stress impairs insulin action and metabolic control is complex
and can occur at several levels to impair signal transduction
and direct or indirect perturbation of specific metabolic
responses. At the signaling level, several mechanisms integrate
ER stress responses with inflammatory and stress signaling
cascades. These include activation of JNK through double-
stranded RNA-dependent protein kinase (PKR) (Nakamura
et al., 2010), via the IRE1/TRAF2/ASK1 (Urano et al., 2000) or
the PERK/CHOP/ERO1L/IP3R/CaMK (Timmins et al., 2009)
pathways, all of which result in impaired insulin receptor
signaling (Hirosumi et al., 2002; Ozcan et al., 2004; Sabio and
Davis, 2010) (Figure 2B). Genetic inhibition of certain aspects
of IRE-1 activity by Bax-inhibitor 1 in the liver tissue also protects
mice against insulin resistance and glucose intolerance (Bailly-
Maitre et al., 2010). Interestingly, PKR is also induced by ER
stress and required for JNK activation (Nakamura et al., 2010)
in cells and whole animals upon short- or long-term exposure
to lipids. PKR forms complexes with insulin receptor signaling
components, inflammatory signaling molecules, and protein
translation machinery, thereby integrating many metabolic and
stress signals (Nakamura et al., 2010). An intriguing possibility
remains that PKR may directly sense a metabolic signal and
serve to assemble a metaflammatory complex that is in play in
metabolic regulation. Other possibilities linking ER function to
metabolic control include alteration of the overall metabolic
context that indirectly contributes to impaired insulin action
through suppressing the secretion of metabolically favorable
hormones such as adiponectin or promote the release of
deleterious ones (Xu et al., 2010) or actions through the
networks between liver and other metabolic organs with the
central nervous system (Purkayastha et al., 2011). Finally, endo-
crine functions of gut and the gut microbiota, which have
profound effects on systemic metabolic homeostasis and
pathological outcomes, also are regulated by ER stress and
related inflammatory signaling pathways (Caricilli et al., 2011;
Kau et al., 2011).
Independent Metabolic Functions
As mentioned before, metabolism in general and glucose and
lipid metabolism in particular could also be regulated through
molecules involved in ER adaptive responses, independent of
insulin action or even ER stress, in a classic sense (Figure 2B).
ATF6 can inhibit the expression of gluconeogenic and lipogenic
genes by binding to TORC2 and SREBP2, respectively, and
suppress their function (Wang et al., 2009; Zeng et al., 2004).
XBP1 (and its yeast homolog, HAC1), as a transcription factorin its own right, directly regulates the expression of a large set
of lipid metabolism genes and hyperactivation promotes hepatic
steatosis (Lee et al., 2008; Acosta-Alvear et al., 2007). XBP1has
also been suggested to suppress hepatic gluconeogenesis by
retaining Foxo1 in the cytosol independent of its own transcrip-
tion activation function (Zhou et al., 2011). Interestingly, deletion
of Xbp1 in the liver was also found to prevent steatosis and
hepatic insulin resistance (Jurczak et al., 2011). Lastly, the
UPR branch traditionally considered as the translational arm,
PERK/eIF2a phosphorylation, also controls lipogenesis through
CEBP/a, PPARg, and SREBP1 (Bobrovnikova-Marjon et al.,
2008). For example, PERK regulates the processing andmatura-
tion of SREBP and its target gene expression in the mammary
gland (Bobrovnikova-Marjon et al., 2008). Hence, there are
multiple direct paths to metabolic regulation from UPR and the
related inflammatory and stress signaling pathways independent
of insulin action (Figure 2B).
Mechanisms of ER Stress in a Metabolic Setting and the
Role of Lipotoxicity
ER stress can be envisioned to proceed in three modes: acute,
periodic, and chronic (Figure 3A). The acute form of ER stress
has been extensively studied and is typically induced by treat-
ment with chemicals (e.g., tunicamycin, DTT, calcium iono-
phores, thapsigargin, saturated fatty acids, and cholesterol)
that induce ER stress. The periodic mode of ER stress is largely
associated with rhythmic or transient physiological activities
(e.g., feeding-fasting cycles) (Pfaffenbach et al., 2010) or tran-
sient infusions of glucose or lipids (Boden et al., 2011), and ER
homeostasis is fully restored after each cycle. Just like acute
inflammation, UPR in this context is an essential part of homeo-
stasis. Chronic ER stress, however, is characterized by a state in
which ER homeostasis is not fully restored during periodic
cycles, either due to the continuous presence of a pre-existing
ER stress inducer or the engagement of UPR in a vicious cycle,
the byproducts of which also compromise ER function.
Chronic ER stress is the mode most relevant to metabolic
health in the condition of nutrient excess, obesity, and insulin
resistance. In recent years, a number of models have been
developed that may explain ER dysfunction and stress in ameta-
bolic context (Hotamisligil, 2010a; Tabas and Ron, 2011; Eizirik
and Cnop, 2010) (Figure 3B). Among mechanistic postulates
inducing ER stress in obesity are protein misfolding by inhibition
of protein N-glycosylation after fructose feeding (Qiu et al.,
2005), protein overload due to increased synthesis of insulin,
apoB, or acute phase proteins or antibodies in the pancreas or
liver of obese subjects (Su et al., 2009; Matveyenko et al.,
2009), lipid synthesis (Fu et al., 2011) or overload leading to the
production of toxic lipid species (Samuel et al., 2010; Summers,
2006; Turpin et al., 2006), or the disruption of membrane struc-
ture and inhibition of membrane protein function (Borradaile
et al., 2006; Li et al., 2004), inflammation reducing membrane,
and chaperone protein function (Uehara et al., 2006; Nakamura
et al., 2010), and defective autophagy (Yang et al., 2010). The
exact mechanism of chronic metabolic ER stress is likely to be
tissue specific and context dependent and may involve the
contribution of multiple pathways. For the purposes of this
manuscript, particular interest will be paid to lipid-induced stress
pathways and their connection to the induction of canonical ERCell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 627
Figure 3. Stress and Adaptation at the Endoplasmic Reticulum
(A) Conceptual models for three modes of ER stress induction with relevance
to overnutrition and chronic disease. Periodic or adaptive UPR, typified by
changes in ER homeostasis during feeding/fasting cycles, or other transient
rhythmic demands, and represented by the black line. In such cases, substrate
overflow and protein synthesis demands challenge the ER, but UPR and
metabolic adaptations such as insulin resistance serve as mechanisms for
restoring ER status. Acute nutrient-induced UPR and ER stress shown in the
red line. This stress is typified by treatments that perturb the ER membrane
composition or functionality directly, such as excess palmitate, cholesterol or
chemicals such as tunicamycin. The relevance of this mode of ER stress to
physiology is questionable, but many of the experimental protocols for the
induction of ER stress follow this model. Chronic ER stress and loss of
adaptive capacity, shown in blue and typified by long term overexposure to
nutrients as in obesity. Under such conditions the ER does not have time,
means, or capacity to fully restore functionality before facing another round of
substrate supply and demand for synthesis. Hence, the ER progressively loses
628 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.
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others but to provide a thorough examination of this aspect.
Acute ER Stress Induction by Lipids
The role of the saturated fatty acid palmitate (16:0), on metabolic
disorders is widely acknowledged. For example, increased
consumption or elevated blood levels of saturated fatty acids
are associated with insulin resistance and the risk of diabetes
in humans (Xiao et al., 2006; Hu et al., 2001; Wang et al., 2003;
Vessby, 2000). This effect has been recapitulated in experi-
mental models, where treatment of cells or animals with palmi-
tate induces acute ER stress and cytotoxicity (Borradaile et al.,
2006; Wei et al., 2006; Erbay et al., 2009). This is likely because
palmitate does not effectively activate triglyceride synthesis
(Lee et al., 2010), and thus it can not be effectively sequestered
into triglycerides unless unsaturated fatty acids are simulta-
neously present or other countermeasures can be deployed
(Listenberger et al., 2003). Consequently, palmitate may be
metabolized to species that induce cytotoxicity: ceramides
(Holland et al., 2007; Unger, 2002), diacylglycerides (Samuel
et al., 2010), reactive oxygen species (Listenberger et al.,
2001), and highly saturated ER membrane phospholipids
(Ariyama et al., 2010).
Excess cholesterol can also induce acute ER stress. Choles-
terol concentrations in the ER are kept exceedingly low through
ER-resident mechanisms (Lange and Steck, 2008). The reason
for the maintenance of low concentrations of cholesterol in the
ER is not entirely clear, but conditions that elevate ER cholesterol
lead to ER stress and loss of SERCA-mediated calcium homeo-
stasis, presumably by promoting the formation of an ordered ER
membrane phase that perturbs SERCA structure (Feng et al.,
2003). Preventing externally loaded cholesterol from cycling to
the ER via inhibitors of cholesterol transport prevents choles-
terol-induced ER stress and cytotoxicity (Feng et al., 2003).
Cholesterol and palmitate can act additively to elicit cytoxicity,
but it is not known whether the effect is a result of a synergistic
membrane ordering effect, or by other additive biochemical
and molecular mechanisms (Pineau et al., 2009).
Unsaturated fatty acids including oleate and palmitoleate
effectively prevent acute ER stress induction under conditions
of either excess palmitate or cholesterol (Pineau et al., 2009; Lis-
tenberger et al., 2003; Peng et al., 2011). The reasons for this in
acute stress have to do with the ability of monounsaturated fatty
acids to support adaptive mechanisms including triglyceridecontrol over metabolism and its own membrane and folding homeostasis,
leading to pathological states.
(B) Factors influencing ER homeostasis and ER stress. Diet, excess caloric
intake, and obesity are prime factors in taxing ER’s homeostatic mechanisms
and capacity. In particular, saturated fat and cholesterol (1), when provided in
excess, can promote the formation of an ordered membrane domain in the ER
that inhibits VLDL formation and SERCA activity, causing a loss of both lipid
clearance and calcium homeostatic capabilities. Additionally, saturated fatty
acids increase ApoB production demands, but are not good substrates for
triglyceride synthesis, and inhibit the clearance of lipid from the ERmembrane
via lipid droplet formation – and may increase the production of lipotoxic
mediators such as ceramides and DAG. Fructose and hyperglycemia (2) can
impair normal protein glycosylation or activate lipogenesis and perturb
membrane properties, leading to UPR. Inflammatory signals (3) increases
demand on hepatic ER for the synthesis and secretion of acute phase proteins,
inhibits SERCA activity, and may compromise UPR. Oxidative stress (4)
resulting from nutrient overload or mitochondrial dysfunction can impair
SERCA and ER chaperone function.
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inhibition of the endogenous ability to convert saturated fatty
acids to unsaturated fatty acids promotes ER stress in cells
and animals (Green and Olson, 2011; Flowers et al., 2008). In
fact, it is feasible to postulate that products of de novo lipogen-
esis such as palmitoleate act to mitigate the potential damaging
effects of saturated fatty acids that, when present in isolation,
disrupt metabolism (Cao et al., 2008; Riquelme et al., 2011).
Chronic ER Stress Induction by Lipids
While monounsaturated fatty acids are established attenuators
of acute palmitate-induced ER stress, excess fatty acid expo-
sure over long periods of time can exceed the capacity, espe-
cially of nonadipose cells, to maintain homeostasis, resulting in
chronic ER stress and lipotoxicity. For example, short-term treat-
ment of cells with oleic acid increases VLDL and triglyceride
secretion, whereas extended incubation of cells with oleic acid
can lead to ER stress and suppression of VLDL secretion (Ota
et al., 2008). Importantly, VLDL secretion and ER homeostasis
under conditions of chronic oleate exposure can be restored
in vivo and in vitro by PBA—a chemical chaperone, demon-
strating that the chronic effects of fatty acids on ER function
are related to compromised chaperone function and more
importantly could be remedied by interventions targeting ER
function (Ota et al., 2008). Likewise PBA alleviates lipid-induced
insulin resistance and b cell dysfunction in humans (Xiao et al.,
2011), although effects of PBA on systems unrelated to its chap-
erone role cannot be ruled out in either setting. Animal models
with increased fatty acid desaturation capacity in extrahepatic
sites are resistant to ER stress and the development ofmetabolic
abnormalities associated with obesity (Cao et al., 2008; Erbay
et al., 2009; Green andOlson, 2011). For example, macrophages
lacking the lipid binding protein aP2 strongly upregulate Scd1
expression, produce copious amounts of palmitoleate, and
become resistant to palmitate-induced ER stress (Erbay et al.,
2009). Adipose and liver tissues of mice with high levels of palmi-
toleate are also devoid of the hallmarks of metabolic disease
commonly found in dyslipidemic or obese mice, consistent
with a protective role for MUFA accumulation (Cao et al.,
2008). In these cases, the source of palmitoleate was extrahe-
patic, allowing the detection of the biology independent of
hepatic lipogenesis. In free-living humans, overall levels of palmi-
toleate in blood are dictated by rates of hepatic lipogenesis, and
therefore total blood palmitoleate may be associated with meta-
bolic risk and increased adiposity (Wang et al., 2003; Paillard
et al., 2008; Navina et al., 2011). Under conditions where palmi-
toleate is increased in away that is dissociated from hepatic lipo-
genesis, we and others have noted its beneficial effects (Cao
et al., 2008; Yang et al., 2011; Matsuzaka et al., 2007; Stefan
et al., 2010; Mozaffarian et al., 2010). In any case, the stress-miti-
gating and cytoprotective mechanisms of unsaturated fatty
acids may be of great importance in understanding ER function
and designing novel strategies for the prevention or treatment of
diabetes and atherosclerosis. While there are many seemingly
competing theories on which particular lipid species is directly
responsible for the acute effects of palmitate (Samuel et al.,
2010; Ussher et al., 2010; Holland et al., 2007), the chronic induc-
tion of ER stress may in fact result from many simultaneous
insults and respond tomany remedies such as reductions in lipid
exposure as a result of caloric restriction, weight loss, andgenetic inhibition of intracellular fatty acid trafficking and
signaling (Tsutsumi et al., 2011; Gregor et al., 2009; Erbay
et al., 2009).
Obesity induces a chronic state of ER stress in mice and hu-
mans (Hotamisligil, 2010b), and it is reasonable to presume
that the mechanism relates, at least in part, to a long-term expo-
sure to lipids. An emerging line of evidence indicates that chronic
ER stress in the liver may be related to subtle alterations in the
phospholipid composition of the ER (Fu et al., 2011). Even with
triglyceride and cholesterol ester synthesis capacity intact
(preventing acute induction of stress by fatty acids) long-term
exposure to lipids can induce the formation of lipid droplets.
These growing droplets require increased synthesis of phospha-
tidylcholine at the ER (Krahmer et al., 2011). In studies systemat-
ically examining hepatic lipid metabolism, we have recently
shown that an imbalance in the phosphatidylcholine/phosphati-
dylethanolamine concentrations in the ER from obese mice is
related to altered SERCA function (Fu et al., 2011). Inhibition of
PEMT, an ER enzyme that converts the endofacial phospholipid
phosphatidylethanolamine to the exofacial phosphatidylcholine,
reversed obesity-driven changes in ER membrane composition
and corrected SERCA dysfunction, ER stress, and abnormal
glucose metabolism (Fu et al., 2011). It is also worth noting
that lipids and fatty acids have a vast array of physical forms
that lead to a variety of functions in diverse lipid pools and their
influence may involve other pathways. Indeed, a recent study
highlighted the ability of the highly unsaturated fatty acid DHA
to induce autophagy (Caviglia et al., 2011), providing perhaps
another mechanism for the maintenance of ER homeostasis
(Yang et al., 2010). Lipids can also engage inflammatory path-
ways directly, although the molecular mediators and the lipid
species involved are not yet established (Wen et al., 2011; Naka-
mura et al., 2010). Considerably more research is necessary,
especially in the specific signaling pathways and functional
networks engaged by specific lipids in the future.
Integration of Stress, Insulin Resistance, and Lipid
Metabolic Pathways
There are currently a number of models put forward to explain
themechanistic linkages among obesity, ER stress, insulin resis-
tance, and type 2 diabetes. These include chronic ‘‘metabolic’’
inflammation or metaflammation characterized by altered pro-
duction of adipokines/cytokines and the infiltration of immune
cells into tissues (Gregor and Hotamisligil, 2011; Olefsky and
Glass, 2010; Shoelson et al., 2006; Lumeng and Saltiel, 2011),
lipotoxicity and ectopic fat accumulation in the liver and perhaps
skeletal muscle (Larson-Meyer et al., 2011; Savage et al., 2007),
and decreased mitochondrial function (Bournat and Brown,
2010; Muoio and Newgard, 2008). These pathways have for
the most part been studied as independent mechanisms for
the induction of insulin resistance. Exploring these mechanisms
in isolation has been extremely useful in simplifying initial exper-
imental approaches; however, the results of these experiments
have led to competing reductionist and compartmentalized
proposals for the central mechanisms of insulin resistance. Inter-
preting these conflicting proposals is logically challenging, and
more integrative interpretations will likely be necessary. The
interconnectedness of metabolism as well as ER pathways
makes it possible to assign the causation of insulin resistanceCell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc. 629
Figure 4. The Concept of Metabolic
Roundabout; an Integrated View of
Metabolic Disruption
An overview of the metabolic roundabout. The
metabolic roundabout regulates the flow of key
metabolic species (vehicles). The level of any
individual metabolite is regulated by a network of
metabolic pathways (denoted by orange and
green arrows respectively). The ability of an
effector (such as insulin) to facilitate the flow of all
metabolites entering the roundabout is con-
strained by the homeostatic balance (entrance/
exit) of each individual metabolite. Blockages or
constrictions of any specific pathway linked to the
metabolic circle will inevitably impair the flow of
other connected metabolic pathways. Nutrient
overabundance – induced traffic jams in the
roundabout can be improved by (1) limiting the
overall inflow of traffic or increasing the number of
lanes (dashed orange arrow), (2) rerouting of traffic
through secondary pathways (dashed black
arrow), or, best of all, (3) repairing the initially
deranged pathway (broken vehicle). The metabo-
lites represented in the metabolic roundabout can
be lipids, inflammatory mediators, neuronal
signals and organelle components, and their
sources can be dietary, cellular and even gut mi-
crobiota-derived. In the case of lipids, they could
be recognized or uptaken by receptors, trans-
porters and cellular organelles, and consequently
trigger metaflammation, ER stress, and mito-
chondrial dysfunction. The activation of chronic
inflammation and impairment of ER and mito-
chondria function can feed-forward contribute to
further deterioration of the aberrant lipid profile by
reducing fatty acid oxidation, promoting lipolysis, and stimulating de novo lipogenesis. Inflammatory mediators can promote lipogenesis, impair mitochondrial
respiratory chain function (NO), and downregulate SERCA expression. Aberrant lipid profiles, impaired mitochondrial function and ER stress, in return, can
promote metaflammation. Lastly, ER stress activates inflammatory cascades (JNK/IKK/CREB pathways), generates ROS, leads to mitochondrial calcium
overload, and activates lipogenesis. Mitochondrial dysfunction, oxidative stress, metaflammation and lipogenesis further exacerbate ER stress by impairing
protein folding (ROS frommitochondria), protein overloading (acute phase proteins of inflammation) and lipid overloading (lipogenesis). Hence, lipid metabolism,
chronic inflammation, and ER stress can all initiate and resolve the problems at the metabolic roundabout when appropriately regulated temporally and spatially.
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question is, therefore, what is the nature of insulin resistance
mechanisms and how are they organized to sustain a chronic
condition?
The observations listed above suggest that the pathways
leading to metabolic dysfunction are not structured in conven-
tional linear and hierarchical networks. Instead, we propose
that independent mechanisms for managing insulin signaling
andmetabolismmay resemble the flow of traffic in a roundabout,
so that individual pathways feed into and interact in a common
conduit (Figure 4). Such an arrangement of pathways for regu-
lating hormone action and metabolism provides a framework
for how individual or collective stresses may provide stimulus
to induce insulin resistance (or other metabolic outcomes), just
as evident in the quantized nature of traffic in a roundabout.
A small but concerted increase in traffic from all input pathways
is capable of stopping flow and disrupting function (i.e., insulin
resistance), but so is an acute level of traffic from any one
contributing pathway, or even a single blockage. As traffic
jams may be propagated if not resolved promptly, initial im-
pairment of singular metabolic functions may lead to chronic
activation of additional insulin resistance pathways, and the
deterioration of metabolic status, i.e., development of diabetes.
In this flow of carbon and energy the roads are all connected
and traffic can be rerouted. Impairments can be relieved without630 Cell Metabolism 15, May 2, 2012 ª2012 Elsevier Inc.addressing all or even any of the original causes, either by iden-
tifying new exits (qualitative) or enhancing existing roadways
(quantitative) (Figure 4). As a qualitative example, the presence
of unsaturated fatty acids can reroute the metabolism of satu-
rated fatty acids and cholesterol toward storage or excretion
(in the forms of triglyceride or cholesterol ester-rich lipid droplets
and lipoproteins) and prevent insulin resistance, without the
need to lower the amount of saturated fatty acids or cholesterol
entering into the system. On the quantitative side, enhancement
of ER function by chemical or molecular chaperones can facili-
tate lipoprotein assembly and excretion and concurrently reduce
fatty acid loading into the roundabout by suppressing de novo
lipogenesis (Ota et al., 2008). Similar interconnectedness also
exists for inflammatory responses, and resolution of this state,
in the appropriate manner, can also liberate the congestion at
the roundabout and improve metabolism (Figure 4).
This roundabout concept is consistent with other proposed
models of insulin resistance including a prevalent hypothesis of
mitochondrial dysfunction involving the accumulation of incom-
pletely oxidized medium chain acylcarnitines (Muoio and New-
gard, 2008). A very important implication of the coordination
and rerouting property of the roundabout structure is that, it
permits the separation of cause and effect under certain condi-
tions and confounds simplistic inference of causality from
genetic studies, which are the foundation of many competing
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Perspectivehypotheses of lipotoxicity and insulin resistance. Thus, inte-
grated, systems-oriented approaches will be necessary in the
future, not only for modeling and examining the contribution of
individual pathways of insulin resistance and interactions
between mechanistic platforms, but also for evaluating the
efficacy of therapeutics in different tissues and pathological
conditions.
The lipid-centric presentation of this concept here is not to
implicate a diminished significance for glucose and/or amino
acid metabolism in the pathogenesis of diabetes and metabolic
syndrome or the interactive nature of pathways involving these
aspects of metabolism. The metabolism of glucose, lipids, and
amino acids are intimately coupled: both the carbon backbone
and the reducing equivalents are passed along among metabo-
lite classes, hence they too can be readily integrated into this
proposal (Figure 4). It is conceivable that the ‘‘traffic compo-
nents’’ in such a roundabout will not be limited to just metabo-
lites, but also include mediators of inflammation, functional
components of cellular organelles, and possibly other elements
such as the input from gut. The exact composition of this meta-
bolic roundabout may vary among different tissues at different
disease states due to their differences in metabolic wiring,
associated energy balance state, and duration of the stimulus.
For example, promoting de novo lipogenesis in adipose tissue
providing metabolic benefit (Cao et al., 2008) in contrast to the
established detrimental effects of lipogenesis in liver and periph-
eral tissues. Similarly, inflammation enhances short-term
mitochondrial function in the muscle and alters energy expendi-
ture, while causing insulin resistance in the liver and adipose
tissues and permanent tissue damage (Thaler et al., 2012).
Features and consequences of ER stress also differ between
metabolic tissues. For example, patterns of ER stress in skeletal
muscle do not resemble those observed in adipose tissue (Oz-
can et al., 2004; Deldicque et al., 2010, 2011). Therefore, the
roundabout organization of insulin resistance pathways
provides a versatile but simple framework for disruptive,
vicious-cycle-like propagation of chronic disease conditions
including diabetes.
Concluding Remarks
Metabolism requires integration of many signals to manage
carbon sources and maintain homeostasis. The fundamental
nature of insulin resistance and metabolic diseases may there-
fore represent an entangled, metastable state of cellular and
whole-body metabolism that is resistant to the anabolic action
of insulin as well as other hormones, rather than the perturbation
of individual metabolic or signaling pathways. It is also clear that
not every aspect of metabolism is directly targeted by insulin or
disrupted by insulin resistance. Perturbations in the central
nervous system also play important roles in the pathogenesis
of metabolic diseases and inflammation (Gautron and Elmquist,
2011; Lumeng and Saltiel, 2011). Finally, the composition of the
gut flora can exert an enormous influence on systemic metabolic
outcomes and at times override the genetic and dietary impact
on disease manifestation (Kau et al., 2011). For this reason, the
mechanism of ER stress in the pathogenesis of abnormal insulin
action and diabetes shall be understood through the metabolic
action of ER and its role as the primary organelle of cellular
anabolic metabolism and a signal-integrating platform, so asother mechanisms regulating systemic metabolic homeostasis
(Figure 4). Opportunities therefore exist to exploit mechanisms
relating to ER management of debilitating substrate flow for
disease prevention or treatment. If this flow is not interrupted
or diverted, overwhelming the ER structure and functional
capacity initiates a vicious cycle of stress, degradation in meta-
bolic control, modification of the ERmembrane itself and awors-
ening of ER stress and functionality. We suggest that lipids play
a unique and crucial role in this cycle because they are both
regulated by the ER and comprise the ER membrane itself. The
notion that increased capacity to cope with lipid overload spares
ER functionality is consistent with findings from genetic experi-
ments showing that by modifying the membrane phospholipid
composition (Fu et al., 2011), promoting the clearance of lipo-
toxic substrate (Listenberger et al., 2003; Flowers et al., 2008),
or by preventing the presentation of lipotoxic substrate to the
ER in the first place (Erbay et al., 2009), ER is protected from
stress and dysfunction with favorable organismic outcomes.
Thus, it may be prudent to consider mechanisms for controlling
ER homeostasis with a focus on the metabolic aspects of ER
function, particularly through the control of lipids, and to exercise
caution on enhancing insulin sensitivity or secretion to overcome
insulin resistance without addressing underlying mechanisms
impairing ER function and the whole organismal context,
including the microbiota, within which such manipulations are
conducted.
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